ABSTRACT
Brain abscess remains a life-threatening condition. Here, we are reporting a case of brain abscess due to Fusobacterium nucleatum in a previously known case of Ebstein anomaly. A 44-year-old male presented with the complaints of headache, and fever. Cerebral imaging revealed parieto-occipital (PO) abscess. The abscess was drained and culture showed growth of Fusobacterium nucleatum. This report illustrates the importance of considering anaerobes as the cause of brain abscess, underscores the usefulness of MALDI, which facilitated the selection of appropriate and prompt adjuvant antibiotic therapy and a favourable outcome.
Subject(s)
Brain Abscess/diagnosis , Brain Abscess/etiology , Ebstein Anomaly/complications , Fusobacterium Infections/diagnosis , Fusobacterium Infections/etiology , Fusobacterium , Adult , Biomarkers , Brain/abnormalities , Brain/diagnostic imaging , Brain/pathology , Brain Abscess/therapy , Combined Modality Therapy , Embolism, Paradoxical/diagnosis , Embolism, Paradoxical/etiology , Fusobacterium Infections/therapy , Humans , Male , Tomography, X-Ray Computed , Treatment OutcomeABSTRACT
The diagnosis and treatment of brain abscesses have advanced due to the utilization of modern microbiological and neurosurgical methods. Here we present a 49-year-old female patient presented with headache and neurological symptoms. Initial evaluation revealed multiple ring-enhanced brain lesions and a lung cavitary lesion initially suspected to represent a malignant process. Stereotactic aspiration provided the diagnosis of brain abscesses but yielded negative cultures. 16S ribosomal RNA analysis enabled the identification of Fusobacterium nucleatum. For ten weeks, the patient was treated with ceftriaxone and metronidazole. A marked clinical and radiological improvement was noted. Brain abscess is a severe intracranial infectious process with significant morbidity and mortality. Microbiological analysis is challenging due to the location of the infection, the broad spectrum of causative agents, and the low yield of cultures. Fusobacterium nucleatum is an anaerobic bacteria with a tendency to abscess formation and is isolated from 2% of brain abscesses. The utilization of 16S RNA analysis improves microbiological identification rates in brain abscesses, as in other infectious entities, enabling better pathogen characterization and more suitable treatment.
Subject(s)
Brain Abscess/diagnosis , Brain Abscess/microbiology , Fusobacterium Infections/diagnosis , Fusobacterium Infections/microbiology , Fusobacterium nucleatum , Immunocompromised Host , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Bacterial Typing Techniques , Brain Abscess/therapy , Drug Therapy, Combination , Female , Fusobacterium Infections/therapy , Fusobacterium nucleatum/classification , Fusobacterium nucleatum/genetics , Fusobacterium nucleatum/isolation & purification , Humans , Middle Aged , RNA, Ribosomal, 16S/genetics , Symptom Assessment , Treatment OutcomeABSTRACT
OBJECTIVE: To evaluate in children the clinical severity and evolution of otogenic lateral sinus thrombosis (OLST) due to Fusobacterium necrophorum compared with other bacterial otogenic thrombosis and propose a specific management flowchart for Fusobacterium OLST. DESIGN: A retrospective multicentre cohort study. SETTINGS: Four French ENT paediatric departments. PARTICIPANTS: A total of 260 under 18 years old admitted for acute mastoiditis were included. Initial imaging was reviewed to focus on complicated mastoiditis and 52 OLST were identified. Children were then divided into two groups according to bacteriological results: 28 in the "OLST Fusobacterium group" and 24 in the "OLST other bacteria group". RESULTS: There was a significant association between F necrophorum and OLST (P < .001). When compared to the OLST other bacteria group, children in the OLST Fusobacterium group were significantly younger (61 months vs 23 months, P < .01) and had a more severe clinical presentation: higher CRP (113 mg/L vs 175.7 mg/L, P = .02) and larger subperiosteal abscess (14 mm vs 21 mm, P < .01). Medical management was also more intensive in the OLST Fusobacterium group than in the OLST other bacteria group: increased number of conservative surgeries (66.7% vs 92.9%, P = .03) and longer hospital stay (13.7 days vs 19.8 days, P = .02). At the end of follow-up, the clinical course was good in both groups without any neurological sequelae. CONCLUSIONS: Thrombotic complications are very frequent in case of Fusobacterium mastoiditis and clinicians should be aware of the initial severity of the clinical presentation. Under appropriate management, the clinical course of Fusobacterium OLST is as good as that of other bacterial otogenic thrombosis.
Subject(s)
Disease Management , Fusobacterium Infections/complications , Fusobacterium necrophorum/isolation & purification , Mastoiditis/complications , Thrombosis/etiology , Acute Disease , Child, Preschool , Female , Fusobacterium Infections/microbiology , Fusobacterium Infections/therapy , Humans , Infant , Male , Mastoiditis/microbiology , Mastoiditis/therapy , Retrospective Studies , Thrombosis/diagnosisABSTRACT
Porphyromonas gingivalis (P. gingivalis) and Fusobacterium nucleatum (F. nucleatum) are Gram-negative anaerobic bacteria possessing several virulence factors that make them potential pathogens associated with periodontal disease. Periodontal diseases are chronic inflammatory diseases of the oral cavity, including gingivitis and periodontitis. Periodontitis can lead to tooth loss and is considered one of the most prevalent diseases worldwide. P. gingivalis and F. nucleatum possess virulence factors that allow them to survive in hostile environments by selectively modulating the host's immune-inflammatory response, thereby creating major challenges to host cell survival. Studies have demonstrated that bacterial infection and the host immune responses are involved in the induction of periodontitis. The NLRP3 inflammasome and its effector molecules (IL-1ß and caspase-1) play roles in the development of periodontitis. We and others have reported that the purinergic P2X7 receptor plays a role in the modulation of periodontal disease and intracellular pathogen control. Caspase-4/5 (in humans) and caspase-11 (in mice) are important effectors for combating bacterial pathogens via mediation of cell death and IL-1ß release. The exact molecular events of the host's response to these bacteria are not fully understood. Here, we review innate and adaptive immune responses induced by P. gingivalis and F. nucleatum infections and discuss the possibility of manipulations of the immune response as therapeutic strategies. Given the global burden of periodontitis, it is important to develop therapeutic targets for the prophylaxis of periodontopathogen infections.
Subject(s)
Bacteroidaceae Infections/microbiology , Fusobacterium Infections/microbiology , Fusobacterium nucleatum/pathogenicity , Periodontal Diseases/microbiology , Porphyromonas gingivalis/pathogenicity , Adaptive Immunity , Animals , Bacteroidaceae Infections/therapy , Caspase 1/metabolism , Cell Survival , Fusobacterium Infections/immunology , Fusobacterium Infections/therapy , Humans , Immunity, Innate , Inflammasomes , Inflammation , Interleukin-1beta/metabolism , Mice , NLR Family, Pyrin Domain-Containing 3 Protein/metabolism , Periodontal Diseases/immunology , Periodontal Diseases/therapy , VirulenceABSTRACT
We describe a patient presenting with constitutional symptoms, poor oral hygiene and leg swelling who was diagnosed with Fusobacterium nucleatum osteomyelitis of femur and empyema. Long bone osteomyelitis is rarely caused by this microorganism. This unusual case was successfully managed with drainage and antimicrobial therapy.
Subject(s)
Empyema/microbiology , Fusobacterium Infections , Fusobacterium nucleatum , Osteomyelitis/microbiology , Anti-Bacterial Agents/therapeutic use , Drainage , Fusobacterium Infections/therapy , Humans , Osteomyelitis/therapyABSTRACT
BACKGROUND: Lemierre disease is a rare postanginal sepsis caused by the anaerobe Fusobacterium necrophorum. It is associated with a pharyngitis that progresses quickly to thrombophlebitis of the internal jugular vein and metastatic abscesses to pulmonary, soft tissue, articular, and organ systems. It is rarely associated with spinal epidural abscesses. Because of the increasing antibiotic resistance, its incidence is on the rise. METHODS: A single-patient case report of an adolescent male who initially presented to our institution for bacteremia and febrile episodes. Over a 1-week course, he developed severe back pain and progressive lower extremity weakness. Advanced imaging revealed an epidural abscess spanning T2-L3 level with extension into the psoas and the paraspinal musculature. Acute management consisted of broad-spectrum intravenous (IV) antibiotics and hemilaminectomy decompression from T2 to L3. The patient completed a 6-week course of IV antibiotics and was followed for a 1-year time period with close clinical follow-up. RESULTS: Blood cultures identified the infecting organism as F. necrophorum. The combination of IV antibiotics and acute hemilaminectomy decompression resulted in successful clearance of the infecting organism with normalization of inflammatory markers and cultures. The patient noted immediate and sustained neurological improvement, with return of full motor and sensory function. At the 1-year timepoint, the patient was able to return to sports and no sagittal/coronal imbalance was noted on radiographs. CONCLUSIONS: An aggressive case of Lemierre disease with extensive epidural abscess formation and neurological weakness was successfully managed with the combination of IV antibiotics and extensive hemilaminectomies for decompression. The patient exhibited no long-term sequela as a result of either the epidural abscess or of its treatment. LEVEL OF EVIDENCE: Level V.
Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Epidural Abscess/therapy , Fusobacterium Infections/therapy , Laminectomy/methods , Lemierre Syndrome/therapy , Lumbar Vertebrae/surgery , Pulmonary Embolism/drug therapy , Thoracic Vertebrae/surgery , Adolescent , Bacteremia/complications , Decompression, Surgical/methods , Drainage , Epidural Abscess/complications , Epidural Abscess/diagnostic imaging , Fever/drug therapy , Fusobacterium Infections/complications , Fusobacterium necrophorum , Humans , Lemierre Syndrome/complications , Lumbar Vertebrae/diagnostic imaging , Magnetic Resonance Imaging , Male , Pulmonary Embolism/etiology , Radiography , Thoracic Vertebrae/diagnostic imagingABSTRACT
There is an increased recovery of Fusobacterium necrophorum from cases of otitis media and mastoiditis in the pediatric population. These infections may be highly severe, causing local osteomyelitis, bacteremia, and Lemierre's syndrome. The severity and difficulties in providing optimal treatment for these infections may be especially difficult in this age group due to immunological immaturity and delayed presentation. In this review of literature, we present and analyze the clinical presentation, management, and outcome of otic infections caused by F. necrophorum in infants and young toddlers less than 2 years old. Search in Pubmed was conducted for reported cases in the English literature for the time period of the last 50 years. Twelve well-described cases were retrieved with F. necrophorum otitis and mastoiditis and complications reported in all cases. Treatment included both intravenously with antimicrobial agents (beta lactams plus metronidazole) and mastoidectomy. Lemierre's syndrome and Lemierre's syndrome variants developed in 60 % of the patients. Dissemination of the infection as distal osteomyelitis and septic shock were also reported. The outcome was favorable in all the cases. Otitis and mastoiditis infections in children less then 2 years old are invasive infections, and severe complications can occur.
Subject(s)
Fusobacterium Infections/microbiology , Fusobacterium necrophorum/physiology , Mastoiditis/microbiology , Otitis/microbiology , Age Factors , Child, Preschool , Fusobacterium Infections/complications , Fusobacterium Infections/diagnosis , Fusobacterium Infections/therapy , Humans , Infant , Infant, Newborn , Mastoiditis/complications , Mastoiditis/diagnosis , Mastoiditis/therapy , Otitis/complications , Otitis/diagnosis , Otitis/therapyABSTRACT
Fusobacterium infection is common in herd animals and caged birds; the infection is typically referred to as "bumble foot" or "foot rot." These are opportunistic anaerobic bacteria that cause abscesses in the feet of animals that have developed inflammation in the foot pad secondary to the terrain. In humans, F. varium is known to cause abscesses associated with the oropharynx and gastrointestinal tract, also known as Lemierre's disease. The present study reports the case of a rare presentation of a F. varium soft tissue infection of the heel pad in a healthy young female with no associated oropharynx or gastrointestinal abscesses. Therefore, her presentation and disease course were similar to that described in herd animals. The patient was treated with 3 weeks of intravenous antibiotics, incision and drainage, and a gracilis free flap to the weightbearing surface of the right heel.
Subject(s)
Fusobacterium Infections/diagnosis , Fusobacterium/isolation & purification , Heel/microbiology , Skin Transplantation/methods , Soft Tissue Infections/therapy , Adult , Ambulatory Care , Anti-Bacterial Agents/therapeutic use , Debridement/methods , Female , Follow-Up Studies , Fusobacterium Infections/therapy , Heel/physiopathology , Heel/surgery , Humans , Infusions, Intravenous , Magnetic Resonance Imaging/methods , Rare Diseases , Reoperation/methods , Severity of Illness Index , Soft Tissue Infections/diagnostic imaging , Treatment Outcome , Wound Healing/physiologyABSTRACT
A 43-year-old man was admitted to our hospital because of an abnormal shadow on chest X-ray. Blood testing showed elevated levels of C-reactive protein and white blood cells. Computed tomography revealed multilocular masses of the right hepatic lobe, reticulonodular shadowing on both lungs, left kidney masses, and aortic arch aneurysm. Fusobacterium nucleatum was isolated from the hepatic abscess after percutaneous transhepatic drainage. Because of severe dental caries, he was diagnosed with liver abscess caused by dental infection with F. nucleatum. Administration of cefmetazole and meropenem was not effective; however, he showed remarkable improvement after treatment with metronidazole and continuous drainage.
Subject(s)
Fusobacterium Infections/complications , Liver Abscess/etiology , Adult , Anti-Infective Agents/therapeutic use , Drainage , Fusobacterium Infections/therapy , Humans , Liver Abscess/therapy , Male , Metronidazole/therapeutic useSubject(s)
Bronchial Fistula/diagnostic imaging , Empyema, Pleural/diagnostic imaging , Pleural Diseases/diagnostic imaging , Ampicillin/therapeutic use , Anti-Bacterial Agents/therapeutic use , Bronchial Fistula/therapy , Campylobacter Infections/diagnostic imaging , Campylobacter Infections/therapy , Campylobacter rectus , Clindamycin/therapeutic use , Diagnosis, Differential , Drainage , Empyema, Pleural/therapy , Fusobacterium Infections/diagnostic imaging , Fusobacterium Infections/therapy , Fusobacterium nucleatum , Humans , Lung Abscess/diagnosis , Male , Middle Aged , Pleural Diseases/therapy , Sulbactam/therapeutic use , ThoracostomySubject(s)
Anti-Bacterial Agents/therapeutic use , Anticoagulants/therapeutic use , Lemierre Syndrome/diagnosis , Lemierre Syndrome/therapy , Adolescent , Adult , Aged , Bacteroides Infections/diagnosis , Bacteroides Infections/therapy , Child , Drainage/methods , Female , Fusobacterium Infections/diagnosis , Fusobacterium Infections/therapy , Humans , Lemierre Syndrome/microbiology , Length of Stay/statistics & numerical data , Male , Methicillin-Resistant Staphylococcus aureus , Michigan , Middle Aged , Mortality , Pharyngitis , Retrospective Studies , Staphylococcal Infections/diagnosis , Staphylococcal Infections/therapy , Streptococcal Infections/diagnosis , Streptococcal Infections/therapy , Young AdultABSTRACT
To characterize patients with parapharyngeal abscess admitted to a Danish tertiary care centre and evaluate our management. This is a retrospective chart review. All records of patients with parapharyngeal abscess admitted to the Ear-Nose-Throat Department at Aarhus University Hospital, Denmark, from January 2001 through December 2011 were reviewed. In total, 63 patients (41 males), aged 4-89 years (median, 45 years) were included in the study. The mean annual incidence of parapharyngeal abscess was 0.9 cases/100,000 population. Thirty-three (52%) patients had concomitant peritonsillar abscess. In two patients the parapharyngeal abscess was accompanied by necrotizing fasciitis. The most frequent surgical approach used was intrapharyngeal incision in combination with tonsillectomy. The most commonly used antibiotic regimen was benzylpenicillin plus metronidazole. Seven (13%) patients returned to the operating theatre due to post-tonsillectomy haemorrhage or insufficient abscess drainage. Tonsillectomy and internal incision of the abscess in combination with a narrow-spectrum intravenous penicillin and metronidazole is a safe and efficient approach for managing parapharyngeal abscesses. This approach, however, carries a relatively high complication rate, requiring close surveillance in the early post-operative period. This is especially true for parapharyngeal abscess patients without peritonsillar abscess. In our series, these patients were more ill, more likely to experience complications, require intensive care, intubation, and tracheotomy, than parapharyngeal abscess patients with concurrent peritonsillar abscess. The frequent co-existence of parapharyngeal abscess and peritonsillar abscess favours careful consideration of addition of tonsillectomy to intrapharyngeal incision.
Subject(s)
Fusobacterium Infections/epidemiology , Peritonsillar Abscess/epidemiology , Pharyngeal Diseases/epidemiology , Streptococcal Infections/epidemiology , Abscess/complications , Abscess/epidemiology , Abscess/therapy , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Child , Child, Preschool , Cohort Studies , Denmark/epidemiology , Drainage/methods , Female , Fusobacterium Infections/complications , Fusobacterium Infections/therapy , Fusobacterium necrophorum/isolation & purification , Humans , Male , Middle Aged , Peritonsillar Abscess/complications , Peritonsillar Abscess/therapy , Pharyngeal Diseases/complications , Pharyngeal Diseases/therapy , Retrospective Studies , Streptococcal Infections/complications , Streptococcal Infections/therapy , Streptococcus pyogenes/isolation & purification , Tonsillectomy , Viridans Streptococci/isolation & purification , Young AdultABSTRACT
We report the case of a 71-year-old woman who presented a primary spinal epidural abscess caused by Fusobacterium necrophorum. This is the second report in the medical literature to associate this organism with a primary spinal epidural abscess without spondylodiscitis. After treatment with emergency laminectomy followed by 8 weeks of antibiotic treatment the patient was cured. Oral metronidazole (500 mg every 8 h) was the definitive choice of treatment. F. necrophorum spinal epidural abscess is rare, although samples for anaerobic culture should be collected in order to improve detection of anaerobic spinal infections. PCR amplification and sequencing of the 16S rRNA permits early diagnosis in anaerobic infections.
Subject(s)
Epidural Abscess/diagnosis , Epidural Abscess/pathology , Fusobacterium Infections/diagnosis , Fusobacterium Infections/pathology , Fusobacterium necrophorum/isolation & purification , Aged , Anti-Bacterial Agents/administration & dosage , Epidural Abscess/microbiology , Epidural Abscess/therapy , Female , Fusobacterium Infections/microbiology , Fusobacterium Infections/therapy , Fusobacterium necrophorum/classification , Fusobacterium necrophorum/genetics , Humans , Laminectomy , Magnetic Resonance Imaging , Polymerase Chain Reaction , RNA, Bacterial/genetics , RNA, Ribosomal, 16S/genetics , Spine/diagnostic imaging , Tomography, X-Ray Computed , Treatment OutcomeSubject(s)
Epidural Abscess/diagnostic imaging , Fusobacterium Infections/diagnostic imaging , Pott Puffy Tumor/diagnostic imaging , Staphylococcal Infections/diagnostic imaging , Anti-Bacterial Agents/therapeutic use , Child , Craniotomy , Drainage , Endoscopy , Epidural Abscess/therapy , Female , Fusobacterium Infections/therapy , Humans , Magnetic Resonance Imaging , Meropenem , Paranasal Sinuses/surgery , Pott Puffy Tumor/therapy , Staphylococcal Infections/therapy , Thienamycins/therapeutic use , Tomography, X-Ray Computed , Vancomycin/therapeutic useABSTRACT
BACKGROUND: Fusobacterium species are uncommon causes of osteomyelitis. These organisms are normal flora of the oral cavity. Therefore, they mostly cause osteomyelitis of the head and neck. Hematogenous osteomyelitis at distant sites other than the head and neck has rarely been reported in pediatric or immunocompromised patients. Here, we report the first case of osteomyelitis of a long bone combined with a muscle abscess due to Fusobacterium nucleatum in an otherwise healthy adult. CASE PRESENTATION: A 59-year-old Korean man was admitted for pain and swelling of the right lower leg, which had been persistent for two weeks. Magnetic resonance imaging showed osteomyelitis of the right fibula with a surrounding muscle abscess of the right lower leg. Incision and drainage was performed, and repetitive tissue cultures grew F. nucleatum. In this patient, it was presumed that recurrent periodontitis caused hematogenous seeding of F. nucleatum to a distant site leading to osteomyelitis with a muscle abscess. The patient was successfully treated with intravenous ampicillin-sulbactam for three weeks and oral amoxicillin-clavulanate for eight weeks. He also underwent repeated surgical drainage. He has no evidence of recurrence after seven months of follow-up. CONCLUSIONS: Clinicians should be aware that F. nucleatum could be the etiologic agent of hematogenous osteomyelitis of a long bone in an immunocompetent patient.
Subject(s)
Actinomycosis/diagnosis , Actinomycosis/pathology , Fusobacterium Infections/diagnosis , Fusobacterium Infections/pathology , Osteomyelitis/diagnosis , Osteomyelitis/pathology , Abscess/diagnosis , Abscess/pathology , Abscess/therapy , Actinomyces/isolation & purification , Actinomycosis/therapy , Adult , Anti-Bacterial Agents/administration & dosage , Coinfection/diagnosis , Coinfection/pathology , Coinfection/therapy , Drainage , Fibula/pathology , Fusobacterium Infections/therapy , Fusobacterium nucleatum/isolation & purification , Humans , Leg/diagnostic imaging , Magnetic Resonance Imaging , Male , Middle Aged , Myositis/diagnosis , Myositis/pathology , Myositis/therapy , Osteomyelitis/complications , Osteomyelitis/therapy , Radiography , Treatment OutcomeABSTRACT
Objectives: Sinus venous thrombosis (SVT) is a rare complication of acute otitis media (AOM) with acute mastoiditis (AM), which during recent years has been associated with Fusobacterium necrophorum (Fn) infection. Our objective was to review clinical, microbiologic, and hematologic features of paediatric otogenic SVT, with a specific focus on the role of Fn. Methods: A retrospective database review in a tertiary paediatric hospital between 2000-2019. Results: Fifty children aged 6-155 months were treated for AM with SVT. Forty-seven (94%) underwent cortical mastoidectomy. Forty-six children received low-molecular-weight heparin (LMWH). Follow-up imaging revealed recanalisation in 92% of cases. No long-term neurologic or haematologic complications were observed. Since 2014, when anaerobic cultures and PCR were routinely used in our institute, Fn was isolated from 15/21 children with SVT. Their time to recanalisation was longer, and the rate of lupus anticoagulant antibodies (LAC) was higher than in the 6 non-Fn patients. Children positive for LAC also had a longer time to recanalisation. Conclusions: Fn is a common pathogen in AM with SVT; its thrombogenic role was demonstrated by a higher prevalence of LAC and a longer time to recanalisation.
Subject(s)
Fusobacterium Infections , Mastoiditis , Otitis Media , Venous Thrombosis , Child , Humans , Fusobacterium Infections/complications , Fusobacterium Infections/therapy , Fusobacterium necrophorum , Heparin, Low-Molecular-Weight , Lupus Coagulation Inhibitor , Mastoiditis/complications , Mastoiditis/microbiology , Otitis Media/complications , Retrospective Studies , Venous Thrombosis/complications , Infant , Child, PreschoolABSTRACT
BACKGROUND: The typical clinical manifestation of an infection with the obligate anaerobic, gram-negative, rod-shaped bacteria Fusobacterium necrophorum is the Lemierre syndrome. As the cause of osteomyelitis and mastoiditis factors of the normal bacteria flora are more likely to be found than Fusobacterium necrophorum. Nevertheless, Necrobacillosis is an important differential diagnosis of complicated courses of mastoiditis. MATERIAL AND METHODS: Because the clinical courses of mastoiditis with osteomyelitis may differ a lot, making the appropriate diagnosis more difficult, consistently and flawless detection of the pathogens is important. Therefore a correct specimen collection, transportation and the subsequent cultivation of the pathogens is essential. RESULTS: The genus Fusobacterium is an obligate anaerobic, gram-negative rod-shaped bacteria. Infections involving the genus Fusobacterium are usually formed endogenously. They are characterized by subacute to chronic, purulent gangrenous necrotizing inflammations. CONCLUSION: As a differential diagnosis, infections with Streptococcus spp., Haemophilus influenzae, Branhamella catarrhalis and Staphylococcus aureus are more likely to cause mastoiditis and osteomyelitis than an infection with Fusobacterium necrophorum. However, the infection with this fusiform bacillus is possible under pathological circumstances e.g. deficiency syndroms, so that when observing a prolonged disease course of mastoiditis an infection with Fusobacterium necrophorum should be considered .
Subject(s)
Fusobacterium Infections/diagnosis , Fusobacterium necrophorum , Mastoiditis/diagnosis , Osteomyelitis/diagnosis , Skull Base , Temporal Bone , Temporomandibular Joint Disorders/diagnosis , Anti-Bacterial Agents/therapeutic use , Bacteriological Techniques , Combined Modality Therapy , Debridement , Diagnosis, Differential , Fusobacterium Infections/therapy , Humans , Lemierre Syndrome/diagnosis , Lemierre Syndrome/therapy , Mastoiditis/therapy , Microbial Sensitivity Tests , Osteomyelitis/therapy , Otitis Media/diagnosis , Otitis Media/therapy , Temporomandibular Joint Disorders/therapy , Tomography, X-Ray ComputedABSTRACT
Probiotics is widespreadly used nowadays. However, the safety issue with the use of live probiotics is still a matter of contention. In recent years, an expanding body of evidence supports the beneficial role of heat-killed probiotics in the maintenance of systemic health, whereas the role of these heat-killed bacteria on periodontal health remains unclear. This study aimed to evaluate the effects of heat-killed probiotics on periodontal pathogen virulence and associated mechanisms. We demonstrated that heat-killed Lactobacillus acidophilus was able to coaggregate with Fusobacterium nucleatum, the bridging bacteria of oral biofilm, and inhibit the adhesion and invasion of F. nucleatum, leading to a subsequent elimination of pro-inflammatory cytokine production in oral epithelial cells. This coaggregation further caused a suppression of the virulence gene fap2 expression in F. nucleatum. Therefore, heat-killed L. acidophilus might downregulate the pro-inflammatory cytokine expression in epithelial cells via coaggregation with F. nucleatum and suppression of F. nucleatum fap2 expression, which was the first demonstration that heat-killed probiotics modulate periodontal disease pathogenesis via coaggregation. Collectively, this finding provides new evidence that heat-killed probiotics might exert beneficial effects to periodontal health by coaggregating with periodontal pathogens and modulating their virulence.
Subject(s)
Bacterial Adhesion/drug effects , Fusobacterium Infections/therapy , Fusobacterium nucleatum/drug effects , Lactobacillus acidophilus/metabolism , Periodontal Diseases/drug therapy , Probiotics/pharmacology , Biofilms/growth & development , Cell Line, Tumor , Cytokines/biosynthesis , Cytokines/immunology , Epithelial Cells/immunology , Epithelial Cells/microbiology , Fusobacterium nucleatum/immunology , Fusobacterium nucleatum/pathogenicity , Hot Temperature , Humans , Periodontal Diseases/microbiologyABSTRACT
BACKGROUND: Lemierre syndrome is a rare disease of the head and neck often affecting adolescents and young adults. Classically, infection begins in the oropharynx with thrombosis of the tonsillar veins followed by involvement of the parapharyngeal space and the internal jugular vein. Septicemia and pulmonary lesions develop as infection spreads via septic emboli. Although a rare entity in modern times, Lemierre syndrome remains a disease of considerable morbidity and potential mortality. METHODS: This was a retrospective review of 3 cases and associated literature. RESULTS: A common 1- to 2-week history of fever, sore throat, neck pain, and fatigue was observed in all patients. Patient 1 developed right facial swelling, neck tenderness, trismus, and tonsillar exudate. Patient 2 displayed right tonsillar erythema and enlargement with right neck tenderness. Patient 3 revealed bilateral tonsillar enlargement with exudate and left neck tenderness. Subsequent studies included blood cultures and computed tomography, after which empiric antibiotic therapy was started. Patient 1 underwent drainage of a right peritonsillar abscess, right pressure equalization tube placement, and ligation of the right external jugular vein. He subsequently developed subdural empyemas, cavernous sinus thrombosis, and carotid artery narrowing and required 9 weeks of antibiotic therapy. Patients 2 and 3 developed pulmonary lesions and received 6 weeks of antibiotic therapy. Timing was crucial in all cases. CONCLUSIONS: Lemierre syndrome is a rare but severe opportunistic infection with poor prognostic outcomes if left untreated. Early diagnosis and treatment is essential. Aggressive antibiotic therapy coupled with surgical intervention, when necessary, provides excellent outcomes.